Search
News
Stocks
Phrontline Biopharma Highlights Encouraging Preliminary Safety and Antitumor Activity of TJ101 Presented at ESMO 2026 and Announces Phase Ib Initiation
Preliminary responses observed in 6 of 8 evaluable urothelial carcinoma patients (75%), including patients previously treated with enfortumab vedotin and pembrolizumab Early antitumor activity also observed in squamous NSCLC, SCLC and prostate cancer SHANGHAI and HANGZHOU, China, Oct. 30, 2026 /PR...PR Newswire
Fri, Oct 30
Commodities
WTI steadies below $102.00 as diplomatic hopes offset Middle East supply risks
West Texas Intermediate (WTI), the US crude oil benchmark, is trading around $101.85 during the early Asian trading hours on Friday. WTI price holds steady as diplomacy hopes for peace talks between the United States (US) and Iran offset some Middle East supply concerns.
Market Movers
XRP (XRPUSD) Is down 2.26% on Oct 30: Key Drivers to Watch
• Fed hawkishness and macro risk-off sentiment triggered broad digital asset liquidations. • Corporate developments failed to drive token demand or spot ETF inflows. • Network activity rose, but technical indicators and escrow releases signaled bearish pressure.TradingKey
Fri, Oct 30
Market Movers
BNB (BNBUSD) Is down 1.91% on Oct 30: Here Is Why
• BNB declined due to security incidents impacting exchange sentiment and risk reduction. • Macroeconomic conditions and forced derivatives liquidations amplified the downward price pressure. • Technical indicators show a sell MACD signal and oversold Williams %R.
TradingKey
Fri, Oct 30
Market Movers
Solana (SOLUSD) Is down 1.97% on Oct 30: What Do On-Chain Data and Market Sentiment Show?
• Persistent spot Solana ETF redemptions weakened institutional demand and market sentiment. • Derivatives deleveraging and forced long liquidations accelerated short-term downward price momentum. • Technical indicators showed a MACD sell signal and oversold Williams %R conditions.
TradingKey
Fri, Oct 30
Stocks
Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering
BOSTON, Oct. 30, 2026 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Nasdaq: BBTX) ("Bambusa Therapeutics" or "Bambusa"), a clinical-stage biopharmaceutical company developing next-generation, long-acting precision bispecific antibodies for immunology and inflammation, today announced t...PR Newswire
Fri, Oct 30
Featured Tools
Top News
DomoAI Launches InkoAI Agent - One Sentence to Ready-to-Post Video
Gold Price Forecast: Gold Tumbles Below $3,900 as Trump Says No Need for Iran Deal; Can October PPI Spur a Rebound?
US October PPI Preview: Fed Rate Hike Expectations Rise, PPI May Be Key Variable; How Will US Stocks, Dollar, and Gold Move?
【US Pre-Market】Nvidia Rebounds Over 2%; Microsoft Falls Over 2% Amid Massive Global Outage; October PPI Due
Nasdaq Extends Drop by 0.91% as Tech Stocks Lead Declines, AMD Falls Nearly 9%, Nvidia Drops 2%
